Skip to main content

Can a blood test detect Alzheimer’s disease?

Thursday, 19 November 2026Personal stories
Dr Marita Long

A new blood test for Alzheimer’s disease, known as pTau217, has generated plenty of excitement as well as raising many questions.

We asked Dementia Australia Medical Advisor Dr Marita Long (pictured above) and WHO-Affiliated Science Communicator Dr Maria Li to answer some of the commonly-asked questions about the test.

Can the blood test diagnose all forms of dementia?

No. Dementia isn’t a single disease. 

Just as there are different types of cancer such as breast, bowel and prostate cancer, there are different types of dementia.

The pTau217 blood test looks for changes linked specifically to Alzheimer’s disease.

Does a positive result mean I have Alzheimer’s disease?

No. A doctor first needs to assess whether there are changes in your memory, thinking or ability to manage everyday life. 

When it is used, the pTau217 blood test is one part of a bigger picture that must include a doctor’s assessment. 

A positive result does not mean you will definitely develop Alzheimer’s disease as many people who test positive will continue to experience healthy cognitive function throughout their lives.

Does a negative result mean I will never develop dementia?

No. A negative result simply means that the test has not found signs of Alzheimer’s disease.

What is it useful for?

Doctors can use the test for someone who is already having problems with their memory or thinking to work out whether Alzheimer’s disease is likely to be contributing.

However, it is still only one part of the picture. 

Some people have more than one type of dementia at the same time, such as Alzheimer’s disease and vascular dementia.

A blood test alone cannot identify the full picture which is why a doctor’s assessment remains essential. 

What it can do is give doctors another important clue when they are trying to work out what is causing someone’s memory or thinking problems. 

A faster and more accurate diagnosis of Alzheimer’s disease may mean fewer invasive tests and earlier access to specialist care and new treatments.

Should I ask my doctor for the blood test as part of my routine health checks?

No. The pTau217 blood test is not intended for people who have no symptoms.

This is because some people who test positive may never develop dementia and, in those situations, a positive result could cause significant worry without providing certainty about the future.

Research brings hope for the future

Dementia Advocate Peggy, who cared for her husband Colin before he died from frontotemporal dementia, said new research developments were very encouraging.

“They give me hope that people affected by dementia and their carers will have more options and a better quality of life,” she said. 

“It is exciting to see so much research already providing practical improvements and tools that can be built upon for the future.”

In her role as a Dementia Advocate, Peggy often shares her experience with researchers and called for continued investment in dementia research.

“Continued investment means that people affected by dementia and their carers are not being forgotten,” she said. 

"It means keeping up the work towards earlier diagnosis, better treatments and more effective care.

“However we need to vastly increase the amount of that investment.”

A final word from the experts

Dr Maria Li
Dr Maria Li

GP and WHO-Affiliated Science Communicator Dr Maria Li (pictured above) said pTau217 doesn’t predict who will develop dementia.

“Right now its greatest value is helping doctors better identify the underlying cause of cognitive impairment in people who are already experiencing symptoms,” Dr Li said.

Dementia Australia Medical Advisor Dr Marita Long (main picture) said blood-based biomarkers such as pTau217 were opening the door to a new era of Alzheimer’s care,  including more targeted treatments and expanded access to clinical trials.

“We’re entering a period of rapid progress in Alzheimer’s research,” Dr Long said. “pTau217 isn’t the magic bullet. It is just the beginning.”

Find out more

Visit the ‘Testing and diagnosis’ page of our website to find out more. 

You can also listen to the ‘Where to from here?’ episode of our podcast Hold the Moment to hear more about what to do after being diagnosed with dementia. 

You can contact the National Dementia Helpline on 1800 100 500 at any time. The Helpline is available 24 hours a day, seven days a week.

Share or print
Last updated
19 November 2026